-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Conference IntroductionSeptember 26-27, 2022 Beijing BPCF Fourth China (Beijing) Biopharmaceutical Technology Summit Forum Highlights
11 parallel sub-forums: Meeting time:
Meeting place:
Main activities:
Meeting content: The
morning of September 26 Plenary AssemblySeptember 26th Morning CDMO Cell and Gene Therapy Production ProcessSeptember 26th afternoon CDMO Antibody Drug Industrialization ProgressSeptember 26th afternoon Process Quality of Cell TherapySeptember 26th Afternoon Antibody Drug Upstream and Downstream Process DevelopmentSeptember 27th Morning ADC drug process development and productionSeptember 27th morning Gene therapy process qualitySeptember 27th morning New vaccine development and evaluationSeptember 27th afternoonQuality analysis and purification platform process developmentSeptember 27th afternoonThe production process of vaccine and Establishment of Vaccine R&D Platform and Production Process Development under the New Epidemic of Quality In the
afternoon of September 27th, the quality control of antibody drugs will be exhibited.
Scope:
11 parallel sub-forums: Meeting time:
Meeting place:
Main activities:
Meeting content: The
morning of September 26 Plenary AssemblySeptember 26th Morning CDMO Cell and Gene Therapy Production ProcessSeptember 26th afternoon CDMO Antibody Drug Industrialization ProgressSeptember 26th afternoon Process Quality of Cell TherapySeptember 26th Afternoon Antibody Drug Upstream and Downstream Process DevelopmentSeptember 27th Morning ADC drug process development and productionSeptember 27th morning Gene therapy process qualitySeptember 27th morning New vaccine development and evaluationSeptember 27th afternoonQuality analysis and purification platform process developmentSeptember 27th afternoonThe production process of vaccine and Establishment of Vaccine R&D Platform and Production Process Development under the New Epidemic of Quality In the
afternoon of September 27th, the quality control of antibody drugs will be exhibited.
Scope:
